Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMGN | Common Stock | Award | $0 | +6.79K | +9.49% | $0.00 | 78.3K | Mar 3, 2025 | Direct | F1 |
holding | AMGN | Common Stock | 876 | Mar 3, 2025 | 401K Plan | F2 |
Id | Content |
---|---|
F1 | These shares include 667 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
F2 | These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. |